2C-O-4

2C-O-4 is a psychedelic and entactogen drug of the 2C family. It was first synthesized by Alexander Shulgin and is used recreationally for its psychoactive effects.

History

2C-O-4 was first synthesized by Alexander Shulgin. In his book PiHKAL, Shulgin lists the dosage as 12–25 mg and the duration as 10–16 hours. He reports that 2C-O-4 produces an increase in synesthesia, the experience of cross-modal sensory effects, and a sense of physical energy.

Pharmacology

Like other 2C drugs, 2C-O-4 is a serotonin receptor agonist. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

Effects

The effects of 2C-O-4 can vary greatly, depending on the dose and individual. At lower doses, effects can include feelings of euphoria, visual hallucinations, and increased awareness of sounds and smells. At higher doses, effects can include intense hallucinations, synesthesia, and a loss of sense of time.

Legal Status

As of 2018, 2C-O-4 is a controlled substance in many countries, including the United States, Australia, and the United Kingdom.

See Also

• 2C
• Alexander Shulgin
• PiHKAL
• Psychedelic drug
• Entactogen

2C-O-4 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia